Androgen Receptor Signaling May Contribute to Melanoma Treatment Resistance
Elisa Becze, BA, ELS, Editor
Voice
Description
Poorer outcomes among males receiving BRAF or MEK inhibitors for melanoma may be related to an increase in androgen receptors, researchers discovered in study findings published in Nature.